Laake K, Telatar M, Geitvik G A, Hansen R O, Heiberg A, Andresen A M, Gatti R, Børresen-Dale A L
Department of Genetics, Norwegian Radium Hospital, Montebello, Oslo, Norway.
Eur J Hum Genet. 1998 May-Jun;6(3):235-44. doi: 10.1038/sj.ejhg.5200181.
The ATM gene is responsible for the autosomal recessive disorder Ataxia-Telangiectasia (AT). Many different mutations, located all across the gene, have been reported with a predominance of truncating mutations. By using PTT (protein truncation test) a mutation was found in one Norwegian AT family. Sequencing revealed that the mutation affected nucleotides 3245-3247, codon 1082, and changed the sequence from ATC to TGAT, inducing a stop codon downstream at codon 1095 and leading to early truncation of the ATM protein. Perpendicular DGGE (denaturing gradient gel electrophoresis) was used to screen 10 additional families for this mutation. The 3245 delATC insTGAT mutation was found in 12 of 22 proband alleles: five patients were homozygotes and two heterozygotes. Haplotype analyses were performed using eight microsatellite markers, within and flanking the ATM gene. All carriers of the mutation described were found to have a common haplotype of the five closest CA-repeat microsatellite markers. Genealogical investigations of the families identified a common ancestor for three of the families. The common ancestor was a woman born in 1684 in the area from which these families originate. The prevalence of this mutation in Norwegian patients now allows a major subset of AT heterozygotes to be identified, both in the general population and in breast cancer patients, so that their cancer risk can be evaluated.
ATM基因与常染色体隐性疾病共济失调毛细血管扩张症(AT)相关。据报道,该基因上存在许多不同的突变,遍布整个基因,其中截断突变占主导。通过使用蛋白质截断试验(PTT),在一个挪威AT家族中发现了一个突变。测序显示该突变影响核苷酸3245 - 3247(密码子1082),使序列从ATC变为TGAT,在密码子1095下游诱导产生一个终止密码子,导致ATM蛋白提前截断。使用垂直变性梯度凝胶电泳(DGGE)对另外10个家族进行该突变的筛查。在22个先证者等位基因中的12个中发现了3245 delATC insTGAT突变:5例患者为纯合子,2例为杂合子。使用ATM基因内部及侧翼的8个微卫星标记进行单倍型分析。所有所述突变携带者均被发现具有5个最接近的CA重复微卫星标记的共同单倍型。对这些家族的系谱调查确定了其中3个家族的共同祖先。这位共同祖先是一位1684年出生于这些家族起源地区的女性。该突变在挪威患者中的流行情况使得现在能够在普通人群和乳腺癌患者中识别出大部分AT杂合子,从而可以评估他们患癌的风险。